Eye Cancer, Intraocular Melanoma
2 clinical trials · Condition
◉ Watch Eye Cancer, Intraocular Melanoma
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma (NCT07136181) | Novelwise Pharmaceutical Corporation | 2025-11-20 |
| Adjuvant Melatonin for Uveal Melanoma (NCT05502900) | Gustav Stalhammar | 2022-10-02 |
Track Eye Cancer, Intraocular Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.